These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1233223)

  • 41. Clinical pharmacology: plasma protein binding of drugs.
    Lindup WE; Orme MC
    Br Med J (Clin Res Ed); 1981 Jan; 282(6259):212-4. PubMed ID: 6779954
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease.
    Hooper WD; Bochner F; Eadie MJ; Tyrer JH
    Clin Pharmacol Ther; 1974 Mar; 15(3):276-82. PubMed ID: 4815953
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma protein binding of bupivacaine and its interaction with other drugs in man.
    Ghoneim MM; Pandya H
    Br J Anaesth; 1974 Jun; 46(6):435-8. PubMed ID: 4458761
    [No Abstract]   [Full Text] [Related]  

  • 45. [Erythrocyte changes during alcoholism and chronic liver diseases].
    Triolo L; Magris D; Mian G; D'Agnolo B
    Arch Sci Med (Torino); 1978; 135(4):477-83. PubMed ID: 756712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1977; 11(1):37-42. PubMed ID: 832656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum lipids and total fatty acids in chronic alcoholic liver disease at different stages of cell damage.
    Marzo A; Ghirardi P; Sardini D; Prandini BD; Albertini A
    Klin Wochenschr; 1970 Aug; 48(15):949-50. PubMed ID: 5519315
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ; Molitoris BA; Nakata LM; Gal J
    Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of parenteral nutrition fluids on the binding of therapeutic drugs to human serum in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):31-4. PubMed ID: 14749546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
    Chien YW; Lambert HJ; Karim A
    J Pharm Sci; 1974 Dec; 63(12):1877-9. PubMed ID: 4449018
    [No Abstract]   [Full Text] [Related]  

  • 53. Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1285-8. PubMed ID: 333094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma protein binding of drugs as a function of age in adult human subjects.
    Bender AD; Post A; Meier JP; Higson JE; Reichard G
    J Pharm Sci; 1975 Oct; 64(10):1711-3. PubMed ID: 1185544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal hormones in alcoholic patients with and without liver disease.
    Dinsmore WW; Callender ME; Love AH; Buchanan KD
    Ulster Med J; 1986 Oct; 55(2):140-6. PubMed ID: 3811012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the Corvac blood collection tube for drug specimen processing.
    Devine JE
    Ther Drug Monit; 1986; 8(2):241-3. PubMed ID: 3726942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.